Stocks · US
VRTX
XNAS
Vertex Pharmaceuticals Inc
An overview for this page is not available in English yet. The figures below are updated daily.
Key figures 2026-10-06 basis
P/E28.97x
P/B6.30x
P/S10.14x
EPS$17.38
ROE21.76%
ROA16.06%
Dividend yield0.00%
EV/EBITDA23.67x
Debt/Equity0.00
Free cash flow$3.8B
Returns and 52-week range
1W-4.64%
1M-8.02%
3M+0.78%
6M+16.31%
1Y+24.55%
YTD+11.10%
52W high$560.25
52W low$402.58
From 52W high-10.34%
Company
Sources and notes
This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.